Raslová, K <br/><br/>
Effect of ciprofibrate on lipoprotien metabolism and oxidative stress parameters in patients with type 2 diabetes mellitus and atherogenic lipoprotein phenotype.  [electronic resource] 

 -  Acta diabetologica  2000 
 - 131-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0940-5429 
<br/><br/><label>Standard No.: </label>10.1007/s005920070015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Glucose--drug effects<br/>Cholesterol--blood<br/>Clofibric Acid--analogs & derivatives<br/>Comet Assay<br/>DNA Damage<br/>Diabetes Mellitus, Type 2--blood<br/>Fibric Acids<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Hypolipidemic Agents--pharmacology<br/>Lipoproteins--blood<br/>Lymphocytes--drug effects<br/>Male<br/>Middle Aged<br/>Oxidative Stress--drug effects<br/>Statistics, Nonparametric<br/>Triglycerides--blood